Add time:07/21/2019         Source:sciencedirect.com

A series of novel pyrimidine analogues were synthesized and evaluated for immunosuppressive activity in the Mixed Lymphocyte Reaction assay, which is well-known as the in vitro model for in vivo rejection after organ transplantation. Systematic variation of the substituents at positions 2, 4 and 6 of the pyrimidine scaffold led to the discovery of 2-benzylthio-5-cyano-6-(4-methoxyphenyl)-4-morpholinopyrimidine with an IC50 value of 1.6 μM in the MLR assay.

We also recommend Trading Suppliers and Manufacturers of 1-(3-METHYLPHENYL)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE (cas 109493-60-9). Pls Click Website Link as below: cas 109493-60-9 suppliers